In the era of evidence-based medicine, randomized controlled trials (RCTs) provide robust evidence for new drug approval, while real-world evidence (RWE) helps reveal the actual performance of drugs in complex and diverse clinical settings. Since its global launch, insulin degludec/insulin aspart has not only demonstrated favorable efficacy and safety in registration trials but also continues […]